Amigos, Mark T.

HRN: 07-72-85  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/11/2026
06/18/2026
IV
500mg
Q8
Mild Tbi Sec To RCI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: